104 related articles for article (PubMed ID: 2531843)
21. Alterations in the extracellular matrix components in human glomerular diseases.
Oomura A; Nakamura T; Arakawa M; Ooshima A; Isemura M
Virchows Arch A Pathol Anat Histopathol; 1989; 415(2):151-9. PubMed ID: 2500770
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
23. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
[TBL] [Abstract][Full Text] [Related]
24. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
[TBL] [Abstract][Full Text] [Related]
25. [Changes in anionic sites on glomerular basement membrane following mesangiolysis--observation in incipient anti-rat Thy1 nephritis].
Ohe K
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1007-14. PubMed ID: 8230810
[TBL] [Abstract][Full Text] [Related]
26. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
[TBL] [Abstract][Full Text] [Related]
27. Glomerular basement membrane proteoglycans are derived from a large precursor.
Klein DJ; Brown DM; Oegema TR; Brenchley PE; Anderson JC; Dickinson MA; Horigan EA; Hassell JR
J Cell Biol; 1988 Mar; 106(3):963-70. PubMed ID: 2964453
[TBL] [Abstract][Full Text] [Related]
28. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
29. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
30. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
31. Distribution of the extracellular matrix components in human glomerular lesions.
Büyükbabani N; Droz D
J Pathol; 1994 Feb; 172(2):199-207. PubMed ID: 8169750
[TBL] [Abstract][Full Text] [Related]
32. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis?
Berden JH; Termaat RM; Brinkman K; Smeenk RJ; Swaak AJ; Faaber P; Assmann K; van de Heuvel LP; Veerkamp JH
Nephrologie; 1989; 10(3):127-32. PubMed ID: 2532712
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
J Histochem Cytochem; 1994 Jan; 42(1):89-102. PubMed ID: 8263327
[TBL] [Abstract][Full Text] [Related]
34. Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats.
Heeringa P; Van den Born J; Brouwer E; Dolman KM; Klok PA; Huitema MG; Limburg PC; Bakker MA; Berden JH; Daha MR; Kallenberg CG
Clin Exp Immunol; 1996 Aug; 105(2):321-9. PubMed ID: 8706341
[TBL] [Abstract][Full Text] [Related]
35. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
Nerlich A
Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
[TBL] [Abstract][Full Text] [Related]
36. Isolation and immunochemical characterization of heparan sulfate rich proteoglycan (HSPG) present in the basement membrane of human placenta.
Onodera S; Sasaki T; Tashiro S
Biol Pharm Bull; 1997 Feb; 20(2):113-7. PubMed ID: 9057969
[TBL] [Abstract][Full Text] [Related]
37. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.
Levidiotis V; Freeman C; Punler M; Martinello P; Creese B; Ferro V; van der Vlag J; Berden JH; Parish CR; Power DA
J Am Soc Nephrol; 2004 Nov; 15(11):2882-92. PubMed ID: 15504941
[TBL] [Abstract][Full Text] [Related]
38. Polycation binding to glomerular basement membrane. Effect of biochemical modification.
Bertolatus JA; Hunsicker LG
Lab Invest; 1987 Feb; 56(2):170-9. PubMed ID: 3807316
[TBL] [Abstract][Full Text] [Related]
39. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
van den Born J; Berden JH
Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
[No Abstract] [Full Text] [Related]
40. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
